ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TAMIFLU
Viral infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

TAMIFLU Rx

Generic Name and Formulations:
Oseltamivir (as phosphate) 30mg, 45mg, 75mg; caps.

Company:
Roche Laboratories

e-Prescribe this drug via Surescripts


Therapeutic Use:

Product Resources »
  • Product Information
  • Coupons, Samples & Vouchers
  • Patient Education and Assistance

Indications for TAMIFLU:

Treatment of uncomplicated acute illness due to influenza infection in patients ≥2 weeks of age who have been symptomatic for ≤2 days. Prophylaxis of influenza in patients ≥1yr of age.

Adult Dose for TAMIFLU:

Start within 2 days of symptom onset or exposure. Unable to swallow caps; use oral susp. If oral susp. unavailable; may open caps and mix with sweetened liquids (eg, regular or sugar-free chocolate syrup, corn syrup, caramel topping, or light brown sugar (dissolved in water). If appropriate strength caps and oral susp. unavailable; have RPh compound an emergency supply of oral susp. from 75mg caps (see full labeling for preparation). ≥13yrs: Treatment: 75mg twice daily for 5 days; CrCl 10–30mL/min: 75mg once daily for 5 days. Prophylaxis: after close contact with infected individual: 75mg once daily for at least 10 days; during community outbreak: 75mg once daily for up to 6 weeks; CrCl 10–30mL/min: 75mg every other day or 30mg once daily.

Children's Dose for TAMIFLU:

Start within 2 days of symptom onset. Unable to swallow caps; use oral susp. If oral susp. unavailable; may open caps and mix with sweetened liquids (eg, regular or sugar-free chocolate syrup, corn syrup, caramel topping, or light brown sugar (dissolved in water). If appropriate strength caps and oral susp. unavailable; have RPh compound an emergency supply of oral susp. from 75mg caps (see full labeling for preparation). Treatment: <2 weeks: not established. Treat for 5 days. ≥2 weeks to <1yr: 3mg/kg twice daily. 1–12yrs: (≤15kg): 30mg twice daily; (15.1–23kg): 45mg twice daily; (23.1–40kg): 60mg twice daily; (≥40.1kg): 75mg twice daily. Prophylaxis: <1yr: not established. Treat for 10 days; during community outbreak: continue up to 6 weeks; 1–12yrs: (≤15kg): 30mg once daily; (15.1–23kg): 45mg once daily; (23.1–40kg): 60mg once daily; (≥40.1kg): 75mg once daily.

See Also:

TAMIFLU ORAL SUSPENSION

Pharmacological Class:

Neuraminidase inhibitor.

Warnings/Precautions:

Not a substitute for influenza vaccination. Hepatic impairment. Chronic cardiac or respiratory disease. Immunocompromised. Monitor for signs of abnormal behavior (esp. in children). Pregnancy (Cat.C). Nursing mothers.

Interactions:

Do not administer live attenuated influenza vaccine within 2 weeks prior or 48 hrs after treatment.

Adverse Reactions:

GI upset, bronchitis, headache, insomnia, vertigo, fatigue; serious skin/hypersensitivity reactions (discontinue if occur), possible neuropsychiatric events (eg, hallucinations, delirium, abnormal behavior).

Metabolism:

Hepatic.

Elimination:

Renal.

Generic Availability:

NO

How Supplied:

Caps—10; Susp—60mL (w. oral dispenser)

TAMIFLU

  • 10 capsules of 75mg dose packs (Qty:1)
  • appx. price $125.00
GoodRx

Sign Up for Free e-newsletters